HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Losing Stock Guy: Why He Went Wrong

By Kevin Matras
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


ANGO: Angiodynamics Inc - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
ANGIODYNAMICS INC (NASD)
ANGO 16.17 -0.02 (-0.12%) Vol.  63,896 15:48 ET
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.

 General Information
ANGIODYNAMICS
603 Queensbury Avenue
Queensbury, NY 12804
Phone: 518-798-1215
Fax: 518-798-3625
Web: www.angiodynamics.com
Email: info@angiodynamics.com
 
Industry MED INSTRUMENTS
Sector: Medical
 
Fiscal Year End May
Last Reported Quarter 08/31/09
Next EPS Date 01/05/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 16.19
52 Week High 16.24
52 Week Low 9.12
Beta 1.16
20 Day Moving Average 150,758.05
Target Price Consensus 14.08
 
 % Price Change
4 Week 2.73
12 Week 26.09
YTD 18.26
 % Price Change Relative to S&P 500
4 Week -1.20
12 Week 13.82
YTD -4.97
 Share Information
Shares Outstanding (millions) 24.50
Market Capitalization (millions) 396.67
Short Ratio 4.46
Last Split Date N/A
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.11
Current Year EPS Consensus Estimate 0.46
Estimated Long-Term EPS Growth Rate 13.30
Next EPS Report Date 01/05/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.75
30 Days Ago 2.75
60 Days Ago 2.75
90 Days Ago 2.75

 Fundamental Ratios
 P/E
Current FY Estimate: 34.94
Trailing 12 Months: 32.38
PEG Ratio 2.62
 EPS Growth
vs. Previous Year 0.00%
vs. Previous Quarter -35.71%
 Sales Growth
vs. Previous Year 13.02%
vs. Previous Quarter: -5.17%
 Price Ratios
Price/Book 1.05
Price/Cash Flow 16.35
Price / Sales 1.98
 ROE
08/31/09 3.25
05/31/09 3.32
02/28/09 3.77
 ROA
08/31/09 2.99
05/31/09 3.04
02/28/09 3.41
 Current Ratio
08/31/09 5.76
05/31/09 5.00
02/28/09 5.20
 Quick Ratio
08/31/09 4.09
05/31/09 3.76
02/28/09 3.95
 Operating Margin
08/31/09 5.99
05/31/09 6.22
02/28/09 7.22
 Net Margin
08/31/09 7.46
05/31/09 7.77
02/28/09 6.04
 Pre-Tax Margin
08/31/09 7.46
05/31/09 7.77
02/28/09 6.04
 Book Value
08/31/09 15.39
05/31/09 15.24
02/28/09 15.10
 Inventory Turnover
08/31/09 2.20
05/31/09 2.38
02/28/09 2.58
 Debt-to-Equity
08/31/09 0.02
05/31/09 0.02
02/28/09 0.02
 Debt to Capital
08/31/09 1.76
05/31/09 1.80
02/28/09 1.82

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research